Creatine synthesis and transport during rat embryogenesis : spatiotemporal expression of AGAT , GAMT and CT 1 Braissant
Creatine synthesis and transport during rat embryogenesis : spatiotemporal expression of AGAT , GAMT and CT 1 Braissant
复制标题
DOI：
--
复制
发表时间：
2009
期刊：
影响因子：
--
通讯作者：
O. Braissant;H. Henry;A. Villard;O. Speer;T. Wallimann;C. Bachmann
中科院分区：
文献类型：
--
作者：
O. Braissant;H. Henry;A. Villard;O. Speer;T. Wallimann;C. Bachmann
BACKGROUND: Creatine (Cr) is synthesized by a two-step mechanism involving arginine:glycine amidinotransferase (AGAT) and guanidinoacetate methyltransferase (GAMT), and is taken up by cells through a specific Cr transporter, CT1. Recently, genetic defects of this pathway have been described, that lead to Cr deficiency, neurological symptoms in early infancy and severe neurodevelopmental delay. To investigate the involvement of Cr synthesis and uptake pathways during embryonic development, we determined the spatiotemporal expression of AGAT, GAMT and CT1 during the rat embryogenesis, at the mRNA and protein level. RESULTS: We show that AGAT and GAMT are expressed in hepatic primordium as soon as 12.5 days, then progressively acquire their adult pattern of expression, with high levels of AGAT in kidney and pancreas, and high levels of GAMT in liver and pancreas. AGAT and CT1 are prominent in CNS, skeletal muscles and intestine, where they appear earlier than GAMT. High levels of CT1 are found in epithelia. CONCLUSION: Our results suggest that de novo synthesis of Cr by AGAT and GAMT, as well as cellular Cr uptake by CT1, are essential during embryonic development. This work provides new clues on how creatine can be provided to developing tissues, and suggests that Cr deficiencies might induce irreversible damages already in utero, particularly on the nervous system. BioMed Central BMC Developmental Biology ss Open Acce Research article Creatine synthesis and transport during rat embryogenesis: Spatiotemporal expression of AGAT, GAMT and CT1 Olivier Braissant*1, Hugues Henry1, Anne-Marie Villard1, Oliver Speer2,3, Theo Wallimann2 and Claude Bachmann1 Address: 1Clinical Chemistry Laboratory, University Hospital, CH-1011 Lausanne, Switzerland, 2Institute of Cell Biology, Swiss Federal Institute of Technology, CH-8093 Zürich, Switzerland and 3Institute of Molecular Biology, University of Zurich, CH-8057 Zürich, Switzerland Email: Olivier Braissant* Olivier.Braissant@chuv.ch; Hugues Henry Hugues.Henry@chuv.ch; Anne-Marie Villard Olivier.Braissant@chuv.ch; Oliver Speer Oliver.Speer@molbio.unizh.ch; Theo Wallimann Theo.Wallimann@cell.biol.ethz.ch; Claude Bachmann Claude.Bachmann@chuv.ch * Corresponding author
